Inovio Pharmaceuticals, Inc.
NUCLEIC ACID ANTIBODY CONSTRUCTS FOR USE AGAINST RESPIRATORY SYNCYTIAL VIRUS
Last updated:
Abstract:
Disclosed herein is a composition including a recombinant nucleic acid sequence that encodes an antibody to a Respiratory Syncytial Virus antigen. Also disclosed herein is a method of generating a synthetic antibody in a subject by administering the composition to the subject. The disclosure also provides a method of preventing and/or treating an Respiratory Syncytial virus infection in a subject using said composition and method of generation.
Status:
Application
Type:
Utility
Filling date:
31 Jan 2019
Issue date:
18 Feb 2021